Application

19069090 · USE OF ONVANSERTIB AS MONOTHERAPY AND IN COMBINATION WITH CETUXIMAB IN TREATING RAS WILD-TYPE COLORECTAL CANCER

Filed 2025-03-03 · Abandoned The official file ↗ · Art unit 1671 · Examiner Michael D Allen Hard · CPC A61K 31/519 · Cardiff Oncology, Inc. · Dickinson Wright PLLC/Cardiff Oncology

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

2.1 mo

to disposition 13.9 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.